X

Stay Connected

Sign Up for Updates

network1.png

PPA strives to improve patient health, advance medical innovation and fuel economic growth.

LEARN MORE
network1.png

The PhRMA Foundation supports the research and career endeavors of scientists in drug discovery and development.

LEARN MORE
network1.png

Access Better Coverage educates consumers about the ABCs of health coverage and access to medicines.

LEARN MORE
network1.png

We Work For Health aims to increase awareness by uniting workers throughout the industry.

LEARN MORE
network1.png

Patent protection should always be considered by an inventor during the initial stages of their invention.

LEARN MORE
logo_white_MyOldMeds-New-1.png

Working to spread awareness and education about the importance of secure drug disposal.

LEARN MORE
LTAC_NEW21.png

Many Americans are struggling to afford their medicines and have important questions about their medicine costs. Let's Talk About Cost addresses these questions.

LEARN MORE
logo_white_LTAM.png

There are a lot of conversations in Washington about how to change Medicare Part D, but they aren't always focused on what seniors care about most: affordability and predictability.

LEARN MORE
 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Safe Drug Disposal is a Viable, Sustainable Option

By Priscilla VanderVeer  |    March 31, 2015
While we missed the opportunity to provide a comment prior to publication, PhRMA’s Assistant General Counsel John Murphy does have a response to the California Healthline article, "Challenged in...   Read More

New Documentary Highlights Tremendous Advances in Cancer Treatment

By Guest Contributor  |    March 30, 2015
Cancer will touch the lives of most Americans, but few understand its history. Cancer: The Emperor of All Maladies, a biography of the disease by award-winning filmmaker Ken Burns, takes on the...   Read More

Medicare Monday: Gaining Part D Coverage Reduces Hospitalizations and Overall Spending in Medicare

By Allyson Funk  |    March 30, 2015
As you learned in last week’s video, Medicare Part D helps seniors adhere to their medicines by providing access to prescription drug coverage. This helps beneficiaries live healthier lives by...   Read More

Week in Review: The Latest from PhRMA

By Allyson Funk  |    March 27, 2015
New report on intellectual property, 5 things you should know about Medicare Part D, and more Biopharmaceutical Industry Leads Manufacturing Sector in R&D Spending - The biopharmaceutical industry...   Read More

Week in Review: Building a Brighter Future for Patients

By Christian Clymer  |    March 27, 2015
When it comes to patient health and well-being, today’s treatment advancements are borne from and stand on the shoulders of investment in prior research and development (R&D). As science continues to...   Read More

Collaboration for Cures: Teaming Up to Advance Science and Save Lives

By Tina Stow  |    March 26, 2015
“Whether it’s our family, our friends, all of us are potentially patients one day.” In a single sentence, Dr. Anthony Coyle, senior vice president and chief scientific officer at Pfizer’s Centers for...   Read More

Ask About Adherence: Q&A with Prescriptions for a Healthy America

By Samantha Dougherty  |    March 26, 2015
Ask About Adherence is a blog series featuring Q&A’s with experts in medication adherence. In this post, we speak with Joel White, Prescriptions for a Healthy America president, on the landscape of...   Read More

Supporting Better Patient Outcomes Through Reform

By Holly Campbell  |    March 25, 2015
Today’s events at the White House and U.S. Department of Health and Human Services (HHS) highlighted the growing interest from policy makers and stakeholders in shifting the health care payment...   Read More

Healthy Outlook: Conquering Cancer in the 21st Century

By Randy Burkholder  |    March 25, 2015
We are at a pivotal juncture in cancer care. As highlighted in recent stories from outlets such as The New  York Times, NPR and TIME, advances in science and technology (such as genomics and health...   Read More

PhRMA Statement on Energy & Commerce Health Subcommittee 340B Hearing

By Allyson Funk  |    March 24, 2015
Today, PhRMA CEO John J. Castellani sent the following statement for the record to the Energy and Commerce Health Subcommittee on the hearing they’re holding on the 340B program:   Read More

A Life-Saving Life’s Work: A Story on the Impact of Clinical Trials

By Guest Contributor  |    March 23, 2015
Clinical trials are an essential step in the process to develop new medicines and as they work to bring about lifesaving new treatments, they also contribute to the local economies where they are...   Read More

Medicare Monday: A Short Video on Medicare Part D

By Allyson Funk  |    March 23, 2015
Medicare Part D provides nearly 40 million older Americans and people living with disabilities with affordable access to prescription drug coverage. There’s a lot of information out there on the Part...   Read More

Biopharmaceutical Industry Leads Manufacturing Sector in R&D Spending

By Mark Grayson  |    March 23, 2015
The biopharmaceutical industry comes out on top as the country’s manufacturing leader in innovation and economic contributions in a new report from ndp | analytics. According to the analysis, the...   Read More

Costs and Consequences of Not Treating High Cholesterol

By Holly Campbell  |    March 20, 2015
Costs and Consequences is a blog series examining the health care burden of not treating diseases. Too often, the rhetoric focuses solely on the cost of medicines and disregards the adverse societal...   Read More

Which 340B Entities Are Getting Most of the Savings?

By Lori Reilly  |    March 19, 2015
When policymakers think about the 340B program, they often think of the thousands of clinics that depend on the 340B program to help underserved populations. The 340B program requires pharmaceutical...   Read More

Medicare Monday: 4 Things You May Not Know about Competition in Part D

By Allyson Funk  |    March 16, 2015
In recent weeks, our #MedicareMonday series has discussed how Part D helps save lives and helps save money for beneficiaries with chronic conditions. Thanks to the program, patients living with high...   Read More

Biopharmaceutical Sector Leads the Way in Clinical Trial Data Sharing

By Bill Chin, M.D.  |    March 15, 2015
Effective and responsible sharing of clinical trial data continues to expand scientific discourse and discovery, as we have chronicled here on the Catalyst. Through the PhRMA-EFPIA Principles for...   Read More

8 Reasons to Celebrate World Kidney Day

By Priscilla VanderVeer  |    March 13, 2015
March is National Kidney Month and the second Thursday of every March is World Kidney Day. So what is it about these bean-shaped organs that make them worthy of recognition? Thirty-one million...   Read More

Costs and Consequences of Not Treating Diseases

By Holly Campbell  |    March 13, 2015
Innovative medicines developed by biopharmaceutical companies are instrumental in helping patients live longer and healthier lives. Since 2000, more than 500 new medicines have been brought to the...   Read More

New Report: Clinical Trials and the Impact on State Economies

By John Corea  |    March 12, 2015
Beyond the profound value that biopharmaceutical industry research and development (R&D) brings patients – new treatments and potential cures for society’s most devastating and costly diseases – are...   Read More

What Access and Affordability Means for Chronic Disease Patients

By Allyson Funk  |    March 12, 2015
For the nearly one in two American adults living with at least one chronic illness, affordability and access to medicine is crucial. Unfortunately, if you have a chronic condition, there may be...   Read More

Use As Directed: Adherence for a Healthier Future

By Samantha Dougherty  |    March 11, 2015
There is a vast and growing evidence base demonstrating that adherence to recommended medication regimens will ultimately deliver better health outcomes for patients such as preventing disease...   Read More

Physicians Deserve Timely Authoritative Risk Information For Medicines

By Jeff Francer  |    March 11, 2015
A Washington Post article today inaccurately describes the Food and Drug Administration’s (FDA) proposed guidance on distributing peer-reviewed scientific and medical information to healthcare...   Read More

I’m Not Average: Jack’s Journey Battling Rare Blood Cancer

By Holly Campbell  |    March 11, 2015
When Jack began to feel winded during daily power walks, little did he know it was the beginning of his journey with Waldenström macroglobulinemia (WM), a rare and incurable blood cancer. Jack was...   Read More

The Five Essential Truths about Prescription Drug Spending

By Robert Zirkelbach  |    March 10, 2015
This blog post has been updated. Every day patients around the world are living healthier, more productive lives thanks to innovative medicines developed by biopharmaceutical companies. Retail...   Read More

Negotiators Must Say “Aloha” to a 21st Century Trade Deal

By Jay Taylor  |    March 10, 2015
This week, chief negotiators from the 12 Pacific Rim countries currently negotiating the Trans-Pacific Partnership (TPP) agreement are gathering in Hawaii to continue deliberations surrounding this...   Read More

Medicare Monday: How Part D Helps Save Lives

By Allyson Funk  |    March 9, 2015
A Wall Street Journal article last month reemphasized what we’ve been discussing in our #MedicareMonday series – Medicare Part D helps save lives. The article discusses new research from the Federal...   Read More

ICYMI: New Study Underscores Access Challenges in Essential Health Benefit Plans

By Allyson Funk  |    March 6, 2015
In the latest analysis of barriers patients face to accessing needed medicines in exchange plans, a new study published in Health Affairs found “on average…exchange plans had…higher deductibles and...   Read More

New Report Highlights a Decade of Innovation in Rare Diseases

By Stephanie Fischer  |    March 5, 2015
Despite Scientific Challenges, Biopharmaceutical Researchers Making Progress against Rare Disease While any given rare disease affects fewer than 200,000 people in the U.S., rare diseases...   Read More

New Analysis: Who Benefits from Contract Pharmacy Arrangements in 340B Program?

By Karyn Schwartz  |    March 3, 2015
How can a program originally designed to help the deserving clinics treating our nation’s most vulnerable patients be used instead to pad the bottom line of large hospitals often providing minimal...   Read More

Patient Assistance Site Relaunched to Better Help Patients, Caregivers

By Holly Campbell  |    March 3, 2015
PhRMA member companies are committed to ensuring patients can access the medicines they need to stay healthy and live longer, more productive lives. As part of this pledge, today we relaunched the ...   Read More

Medicare Monday: Helping Hypertensive Patients Live Healthier Lives

By Allyson Funk  |    March 2, 2015
Hypertension, or high blood pressure, is a chronic condition affecting an estimated 70 million people in the United States. Unfortunately, just 52 percent of these individuals have their high blood...   Read More

PhRMA’s John Castellani Gives Attendees a 2015 Leukemia Ball Sneak Peek

By John Castellani  |    March 2, 2015
This piece first appeared on WashingtonExec on February 25, 2015. On Saturday, March 28, the Leukemia & Lymphoma Society (LLS) will host its 2015 Leukemia Ball. This annual black-tie event starts at...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates

Trending Posts

Most Popular Posts

Pharmaceutical Research and Manufacturers of America®
950 F Street, NW Suite 300, Washington, DC 20004

Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how
we and third parties use pixel tags, and how that use affects you, visit our privacy policy and review
"1. Information Collection."